Literature DB >> 4029255

Ageing and acetylator phenotype as determined by administration of sulphadimidine.

A E Pontiroli, A De Pasqua, L Bonisolli, G Pozza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4029255     DOI： 10.1007/bf00544374

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  8 in total

1.  HUMAN ACETYLATION POLYMORPHISM.

Authors:  D A EVANS; T A WHITE
Journal:  J Lab Clin Med       Date:  1964-03

2.  Hepatic drug acetylation and oxidation: effects of aging in man.

Authors:  F Farah; W Taylor; M D Rawlins; O James
Journal:  Br Med J       Date:  1977-07-16

Review 3.  Disease and acetylation polymorphism.

Authors:  P K Lunde; K Frislid; V Hansteen
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

4.  An improved and simplified method of detecting the acetylator phenotype.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1969-12       Impact factor: 6.318

5.  Acetylator phenotypes: effect of age.

Authors:  B Gachályi; A Vas; P Hajós; A Káldor
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer.

Authors:  R A Cartwright; R W Glashan; H J Rogers; R A Ahmad; D Barham-Hall; E Higgins; M A Kahn
Journal:  Lancet       Date:  1982-10-16       Impact factor: 79.321

7.  Diabetic dimorphism according to acetylator status.

Authors:  A W Burrows; T D Hockaday; J I Mann; J G Taylor
Journal:  Br Med J       Date:  1978-01-28

8.  Determination of the acetylator phenotype and pharmacokinetics of some sulphonamides in man.

Authors:  T B Vree; W J O'Reilly; Y A Hekster; J E Damsma; E van der Kleijn
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447
  8 in total
  4 in total

Review 1.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

2.  Influence of age, sex and body weight on the dapsone acetylation phenotype.

Authors:  P A Philip; S L Gayed; H J Rogers; P Crome
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

3.  Ageing and acetylator phenotype.

Authors:  B Gachályi; A Vas; A Káldor
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  Acetylation and oxidation phenotypes in malignant lymphoma.

Authors:  P A Philip; H J Rogers; P G Harper
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.